These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37356935)

  • 41. Enhanced Detection of Genitourinary Cancers Using Fragmentation and Copy Number Profiles Obtained from Urinary Cell-Free DNA.
    Han Y; Li X; Zhang M; Yang Y; Ge G; Wang K; Gong Y; Liang Y; Niu H; Ci W
    Clin Chem; 2021 Jan; 67(2):394-403. PubMed ID: 33523215
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High resolution array comparative genomic hybridization identifies copy number alterations in diffuse large B-cell lymphoma that predict response to immuno-chemotherapy.
    Kreisel F; Kulkarni S; Kerns RT; Hassan A; Deshmukh H; Nagarajan R; Frater JL; Cashen A
    Cancer Genet; 2011 Mar; 204(3):129-37. PubMed ID: 21504712
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exploring biomarkers for prognosis and neoadjuvant chemosensitivity in rectal cancer: Multi-omics and ctDNA sequencing collaboration.
    Jiang XF; Zhang BM; Du FQ; Guo JN; Wang D; Li YE; Deng SH; Cui BB; Liu YL
    Front Immunol; 2022; 13():1013828. PubMed ID: 36569844
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genomewide copy number alteration screening of circulating plasma DNA: potential for the detection of incipient tumors.
    Lenaerts L; Vandenberghe P; Brison N; Che H; Neofytou M; Verheecke M; Leemans L; Maggen C; Dewaele B; Dehaspe L; Vanderschueren S; Dierickx D; Vandecaveye V; Amant F; Vermeesch JR
    Ann Oncol; 2019 Jan; 30(1):85-95. PubMed ID: 30371735
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma.
    Cherng HJ; Sun R; Sugg B; Irwin R; Yang H; Le CC; Deng Q; Fayad L; Fowler NH; Parmar S; Steiner R; Hagemeister F; Nair R; Lee HJ; Rodriguez M; Samaniego F; Iyer SP; Flowers CR; Wang L; Nastoupil LJ; Neelapu SS; Ahmed S; Strati P; Green MR; Westin J
    Blood; 2022 Aug; 140(5):504-515. PubMed ID: 35512184
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Non-invasive detection of lymphoma with circulating tumor DNA features and protein tumor markers.
    Chang Y; Li S; Li Z; Wang X; Chang F; Geng S; Zhu D; Zhong G; Wu W; Chang Y; Tu S; Mao M
    Front Oncol; 2024; 14():1341997. PubMed ID: 38313801
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Copy number profiling of circulating free DNA predicts transarterial chemoembolization response in advanced hepatocellular carcinoma.
    Dong X; Chen G; Huang X; Li Z; Peng F; Chen H; Zhou Y; He L; Qiu L; Cai Z; Liu J; Liu X
    Mol Oncol; 2022 May; 16(10):1986-1999. PubMed ID: 34939323
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of cfDNA as an early detection assay for dense tissue breast cancer.
    Barbirou M; Miller AA; Gafni E; Mezlini A; Zidi A; Boley N; Tonellato PJ
    Sci Rep; 2022 May; 12(1):8458. PubMed ID: 35589867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genomic variations in plasma cell free DNA differentiate early stage lung cancers from normal controls.
    Xia S; Huang CC; Le M; Dittmar R; Du M; Yuan T; Guo Y; Wang Y; Wang X; Tsai S; Suster S; Mackinnon AC; Wang L
    Lung Cancer; 2015 Oct; 90(1):78-84. PubMed ID: 26233568
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cell-Free DNA Detection of Tumor Mutations in Heterogeneous, Localized Prostate Cancer Via Targeted, Multiregion Sequencing.
    Chen E; Cario CL; Leong L; Lopez K; Márquez CP; Li PS; Oropeza E; Tenggara I; Cowan J; Simko JP; Kageyama R; Wells DK; Chan JM; Friedlander T; Aggarwal R; Paris PL; Feng F; Carroll PR; Witte JS
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34250416
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genome-wide somatic copy number alteration analysis and database construction for cervical cancer.
    Luo H; Xu X; Yang J; Wang K; Wang C; Yang P; Cai H
    Mol Genet Genomics; 2020 May; 295(3):765-773. PubMed ID: 31901979
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MYC or BCL2 copy number aberration is a strong predictor of outcome in patients with diffuse large B-cell lymphoma.
    Lu TX; Fan L; Wang L; Wu JZ; Miao KR; Liang JH; Gong QX; Wang Z; Young KH; Xu W; Zhang ZH; Li JY
    Oncotarget; 2015 Jul; 6(21):18374-88. PubMed ID: 26158410
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A pilot prospective study of plasma cell-free DNA whole-genome sequencing identified chromosome 7p copy number gains as a specific biomarker for early lung cancer detection.
    Yu HJ; Yu XJ; Tang J; Lu X; Ma HT
    Neoplasma; 2021 May; 68(3):567-571. PubMed ID: 33618519
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A computational framework to unify orthogonal information in DNA methylation and copy number aberrations in cell-free DNA for early cancer detection.
    Wei Q; Jin C; Wang Y; Guo S; Guo X; Liu X; An J; Xing J; Li B
    Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35649341
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Massively parallel sequencing of cell-free DNA in plasma for detecting gynaecological tumour-associated copy number alteration.
    Nakabayashi M; Kawashima A; Yasuhara R; Hayakawa Y; Miyamoto S; Iizuka C; Sekizawa A
    Sci Rep; 2018 Jul; 8(1):11205. PubMed ID: 30046040
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative genomic hybridization shows complex genomic changes of plasmacytoid urothelial carcinoma.
    Keck B; Ellmann C; Stoehr R; Weigelt K; Goebell PJ; Kunath F; Taubert H; Hartmann A; Wullich B; Wach S
    Urol Oncol; 2014 Nov; 32(8):1234-9. PubMed ID: 25087089
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The analysis of cell-free DNA concentrations and integrity in serum of initial and treated of lymphoma patients.
    Wu J; Tang W; Huang L; Hou N; Wu J; Cheng X; Ma D; Qian P; Shen Q; Guo W; Peng W; Liu Y; Jiang C; Feng J
    Clin Biochem; 2019 Jan; 63():59-65. PubMed ID: 30292543
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liquid biopsy detection of genomic alterations in pediatric brain tumors from cell-free DNA in peripheral blood, CSF, and urine.
    Pagès M; Rotem D; Gydush G; Reed S; Rhoades J; Ha G; Lo C; Fleharty M; Duran M; Jones R; Becker S; Haller M; Sinai CE; Goumnerova L; Golub TR; Love JC; Ligon KL; Wright KD; Adalsteinsson VA; Beroukhim R; Bandopadhayay P
    Neuro Oncol; 2022 Aug; 24(8):1352-1363. PubMed ID: 34984433
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Unsupervised detection of fragment length signatures of circulating tumor DNA using non-negative matrix factorization.
    Renaud G; Nørgaard M; Lindberg J; Grönberg H; De Laere B; Jensen JB; Borre M; Andersen CL; Sørensen KD; Maretty L; Besenbacher S
    Elife; 2022 Jul; 11():. PubMed ID: 35894300
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of 6q deletions in mature B cell lymphomas and childhood acute lymphoblastic leukemia.
    Thelander EF; Ichimura K; Corcoran M; Barbany G; Nordgren A; Heyman M; Berglund M; Mungall A; Rosenquist R; Collins VP; Grandér D; Larsson C; Lagercrantz S
    Leuk Lymphoma; 2008 Mar; 49(3):477-87. PubMed ID: 18297524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.